The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), Splunk (NASDAQ:SPLK).
The investment seeks to provide long-term capital appreciation.
The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with the potential for above average earnings growth. It may invest in stocks across all market sectors and market capitalizations. Although it has historically invested primarily in large- and mid-capitalization companies, it has also invested a significant portion of its assets in small-capitalization stocks.
The average market capitalization across the PRIMECAP Odyssey Growth MF is 380.16B. The market cap for tickers in the group ranges from 12.05B to 2.84T. MSFT holds the highest valuation in this group at 2.84T. The lowest valued company is ACM at 12.05B.
The average weekly volume growth across all stocks in the PRIMECAP Odyssey Growth MF was 112%. For the same stocks of the MF, the average monthly volume growth was 8% and the average quarterly volume growth was -8%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 67
P/E Growth Rating: 49
Price Growth Rating: 45
SMR Rating: 58
Profit Risk Rating: 40
Seasonality Score: 16 (-100 ... +100)